Countermeasures against COVID-19: how to navigate medical practice through a nascent, evolving evidence base - a European multicentre mixed methods study
Language English Country Great Britain, England Media electronic
Document type Journal Article, Multicenter Study
PubMed
33597140
PubMed Central
PMC7893209
DOI
10.1136/bmjopen-2020-043015
PII: bmjopen-2020-043015
Knihovny.cz E-resources
- Keywords
- COVID-19, health & safety, health policy, nephrology, paediatrics, qualitative research,
- MeSH
- COVID-19 prevention & control MeSH
- Renal Dialysis MeSH
- Child MeSH
- Infection Control MeSH
- Humans MeSH
- Nephrology organization & administration MeSH
- Pandemics * MeSH
- Pediatrics organization & administration MeSH
- Delivery of Health Care organization & administration MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Geographicals
- Europe MeSH
OBJECTIVES: In a previously published Delphi exercise the European Pediatric Dialysis Working Group (EPDWG) reported widely variable counteractive responses to COVID-19 during the first week of statutory public curfews in 12 European countries with case loads of 4-680 infected patients per million. To better understand these wide variations, we assessed different factors affecting countermeasure implementation rates and applied the capability, opportunity, motivation model of behaviour to describe their determinants. DESIGN: We undertook this international mixed methods study of increased depth and breadth to obtain more complete data and to better understand the resulting complex evidence. SETTING: This study was conducted in 14 paediatric nephrology centres across 12 European countries during the COVID-19 pandemic. PARTICIPANTS: The 14 participants were paediatric nephrologists and EPDWG members from 12 European centres. MAIN OUTCOME MEASURES: 52 countermeasures clustered into eight response domains (access control, patient testing, personnel testing, personal protective equipment policy, patient cohorting, personnel cohorting, suspension of routine care, remote work) were categorised by implementation status, drivers (expert opinion, hospital regulations) and resource dependency. Governmental strictness and media attitude were independently assessed for each country and correlated with relevant countermeasure implementation factors. RESULTS: Implementation rates varied widely among response domains (median 49.5%, range 20%-71%) and centres (median 46%, range 31%-62%). Case loads were insufficient to explain response rate variability. Increasing case loads resulted in shifts from expert opinion-based to hospital regulation-based decisions to implement additional countermeasures despite increased resource dependency. Higher governmental strictness and positive media attitude towards countermeasure implementation were associated with higher implementation rates. CONCLUSIONS: COVID-19 countermeasure implementation by paediatric tertiary care centres did not reflect case loads but rather reflected heterogeneity of local rules and of perceived resources. These data highlight the need of ongoing reassessment of current practices, facilitating rapid change in 'institutional behavior' in response to emerging evidence of countermeasure efficacy.
Department of Pediatric Nephrology Hôpital Femme Mère Enfant Hospices Civils de Lyon Lyon France
Department of Pediatric Nephrology KfH Children's Kidney Center Marburg Germany
Department of Pediatric Nephrology Medical University of Gdansk Gdansk Poland
Department of Pediatric Nephrology Mitera Children's Hospital Athens Greece
Department of Pediatric Nephrology University Hospital Motol Prague Czech Republic
Department of Pediatric Nephrology University Hospital Vall d'Hebron Barcelona Spain
Department of Pediatric Nephrology Utoped Universitair Ziekenhuis Gent Ghent Belgium
Dialysis Unit Department of Pediatrics IRCCS Giannina Gaslini Genoa Italy
Division of Pediatric Nephrology Gazi University Faculty of Medicine Ankara Turkey
Ludwig Boltzmann Institute for Arthritis and Rehabilitation Vienna Austria
Pediatric Center Institute of Clinical Medicine Vilnius University Vilnius Lithuania
Research Platform Data Science University of Vienna Vienna Austria
See more in PubMed
Anderson RM, Heesterbeek H, Klinkenberg D, et al. . How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet 2020;395:931–4. 10.1016/S0140-6736(20)30567-5 PubMed DOI PMC
Chen S, Yang J, Yang W, et al. . COVID-19 control in China during mass population movements at new year. Lancet 2020;395:764–6. 10.1016/S0140-6736(20)30421-9 PubMed DOI PMC
Feng S, Shen C, Xia N, et al. . Rational use of face masks in the COVID-19 pandemic. Lancet Respir Med 2020;8:434–6. 10.1016/S2213-2600(20)30134-X PubMed DOI PMC
Flahault A COVID-19 cacophony: is there any orchestra conductor? Lancet 2020;395:1037. 10.1016/S0140-6736(20)30491-8 PubMed DOI PMC
Eibensteiner F, Ritschl V, Ariceta G, et al. . Rapid response in the COVID-19 pandemic: a Delphi study from the European pediatric dialysis Working group. Pediatr Nephrol 2020;35:1669–78. 10.1007/s00467-020-04584-6 PubMed DOI PMC
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011;6:42. 10.1186/1748-5908-6-42 PubMed DOI PMC
Ritschl V, Lackner A, Boström C, et al. . I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis. Arthritis Res Ther 2018;20:234. 10.1186/s13075-018-1732-7 PubMed DOI PMC
Johnson RB, Onwuegbuzie AJ, Turner LA. Toward a definition of mixed methods research. J Mix Methods Res 2007;1:112–33. 10.1177/1558689806298224 DOI
Johnson RB, Onwuegbuzie AJ. Mixed methods research: a research paradigm whose time has come. Educational Researcher 2004;33:14–26. 10.3102/0013189X033007014 DOI
Creswell JW Research design: qualitative, quantitative, and mixed methods approaches. SAGE Publications, 2013. PubMed
European centre for disease prevention and control (ECDC) COVID-19 situation update worldwide, as of 6 April 2020. Available: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases [Accessed 6 Apr 2020].
Eurostat, Europe’s population on January the 1st 2019. Available: https://ec.europa.eu/eurostat/tgm/table.do?tab=table&plugin=1&language=en&pcode=tps00001 [Accessed 6 Apr 2020].
Pan A, Liu L, Wang C, et al. . Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA 2020;323:1915–23. 10.1001/jama.2020.6130 PubMed DOI PMC
Koh D, Goh HP. Occupational health responses to COVID-19: what lessons can we learn from SARS? J Occup Health 2020;62:e12128. 10.1002/1348-9585.12128 PubMed DOI PMC
Essack SY, Sartorius B. Global antibiotic resistance: of contagion, confounders, and the COM-B model. Lancet Planet Health 2018;2:e376–7. 10.1016/S2542-5196(18)30187-6 PubMed DOI
Greenberg N, Docherty M, Gnanapragasam S, et al. . Managing mental health challenges faced by healthcare workers during covid-19 pandemic. BMJ 2020;368:m1211. 10.1136/bmj.m1211 PubMed DOI
Zhao R, Zhou Q, Wang X-W, et al. . COVID-19 outbreak and management approach for families with children on long-term kidney replacement therapy. Clin J Am Soc Nephrol 2020;15:1259–66. 10.2215/CJN.03630320 PubMed DOI PMC
Ji Y, Ma Z, Peppelenbosch MP, et al. . Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health 2020;8:e480. 10.1016/S2214-109X(20)30068-1 PubMed DOI PMC
Djulbegovic B, Guyatt G. Evidence vs consensus in clinical practice guidelines. JAMA 2019:1:725. 10.1001/jama.2019.9751 PubMed DOI PMC
Garrett L COVID-19: the medium is the message. Lancet 2020;395:942–3. 10.1016/S0140-6736(20)30600-0 PubMed DOI PMC
Cowling BJ, Ali ST, Ng TWY, et al. . Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health 2020;5:e279–88. 10.1016/S2468-2667(20)30090-6 PubMed DOI PMC
Anderson M, Mckee M, Mossialos E. Covid-19 exposes weaknesses in European response to outbreaks. BMJ 2020;368:m1075. 10.1136/bmj.m1075 PubMed DOI
Chao M, Xue D, Liu T, et al. . Media use and acute psychological outcomes during COVID-19 outbreak in China. J Anxiety Disord 2020;74:102248. 10.1016/j.janxdis.2020.102248 PubMed DOI PMC
Reiter T, Pajenda S, Wagner L. Covid-19 serology in nephrology health care workers. medRxiv 2020;20136218.
Cramton P, Ockenfels A, Roth AE, et al. . Borrow crisis tactics to get COVID-19 supplies to where they are needed. Nature 2020;582:334–6. 10.1038/d41586-020-01750-6 PubMed DOI
Okazawa M, Suzuki S. Japanese tactics for suppressing COVID-19 spread. Public Health 2020;186:6–7. 10.1016/j.puhe.2020.07.012 PubMed DOI PMC
Shen Q, Wang M, Che R, et al. . Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pediatr Nephrol 2020;35:1351–7. 10.1007/s00467-020-04555-x PubMed DOI PMC
Schneider EC Failing the Test - The Tragic Data Gap Undermining the U.S. Pandemic Response. N Engl J Med 2020;383:299–302. 10.1056/NEJMp2014836 PubMed DOI
Schwierzeck V, König JC, Kühn J. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit. Clin Infect Dis 202010.1093/cid/ciaa491 PubMed DOI PMC
Chu DK, Akl EA, Duda S, et al. . Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 2020;395:1973–87. 10.1016/S0140-6736(20)31142-9 PubMed DOI PMC
Mak TK, Lim JC, Thanaphollert P, et al. . Global regulatory agility during covid-19 and other health emergencies. BMJ 2020;369:m1575. 10.1136/bmj.m1575 PubMed DOI
Ruktanonchai NW, Floyd JR, Lai S, et al. . Assessing the impact of coordinated COVID-19 exit strategies across Europe. Science 2020;369:1465–70. 10.1126/science.abc5096 PubMed DOI PMC
Progress in Biosensors for the Point-of-Care Diagnosis of COVID-19